192 related articles for article (PubMed ID: 31396300)
1. Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway.
Huang T; Zhou F; Yuan X; Yang T; Liang X; Wang Y; Tu H; Chang J; Nan K; Wei Y
Oxid Med Cell Longev; 2019; 2019():5813985. PubMed ID: 31396300
[TBL] [Abstract][Full Text] [Related]
2. Depression accelerates the development of gastric cancer through reactive oxygen species‑activated ABL1 (Review).
Huang T; Zhou F; Wang-Johanning F; Nan K; Wei Y
Oncol Rep; 2016 Nov; 36(5):2435-2443. PubMed ID: 27666407
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
Cao Y; Wang J; Tian H; Fu GH
J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
[TBL] [Abstract][Full Text] [Related]
4. (S)-crizotinib reduces gastric cancer growth through oxidative DNA damage and triggers pro-survival akt signal.
Ji J; Chen W; Lian W; Chen R; Yang J; Zhang Q; Weng Q; Khan Z; Hu J; Chen X; Zou P; Chen X; Liang G
Cell Death Dis; 2018 May; 9(6):660. PubMed ID: 29855474
[TBL] [Abstract][Full Text] [Related]
5. ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
Wang F; Hou W; Chitsike L; Xu Y; Bettler C; Perera A; Bank T; Cotler SJ; Dhanarajan A; Denning MF; Ding X; Breslin P; Qiang W; Li J; Koleske AJ; Qiu W
Gastroenterology; 2020 Jul; 159(1):289-305.e16. PubMed ID: 32171747
[TBL] [Abstract][Full Text] [Related]
6. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
[TBL] [Abstract][Full Text] [Related]
7. Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3/JAK2 signaling regulated by ROS.
Liang JR; Yang H
Biomed Pharmacother; 2020 May; 125():109585. PubMed ID: 32106377
[TBL] [Abstract][Full Text] [Related]
8. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
9. BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer.
Liu JZ; Hu YL; Feng Y; Jiang Y; Guo YB; Liu YF; Chen X; Yang JL; Chen YY; Mao QS; Xue WJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):123. PubMed ID: 32605589
[TBL] [Abstract][Full Text] [Related]
10. Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway.
Zhang G; Li Z; Dong J; Zhou W; Zhang Z; Que Z; Zhu X; Xu Y; Cao N; Zhao A
BMC Complement Med Ther; 2022 Jan; 22(1):10. PubMed ID: 35000605
[TBL] [Abstract][Full Text] [Related]
11. Global identification of circular RNAs in imatinib (IM) resistance of chronic myeloid leukemia (CML) by modulating signaling pathways of circ_0080145/miR-203/ABL1 and circ 0051886/miR-637/ABL1.
Lu YH; Huang ZY
Mol Med; 2021 Nov; 27(1):148. PubMed ID: 34781898
[TBL] [Abstract][Full Text] [Related]
12. Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate.
Rausch JL; Boichuk S; Ali AA; Patil SS; Liu L; Lee DM; Brown MF; Makielski KR; Liu Y; Taguchi T; Kuan SF; Duensing A
Oncotarget; 2017 Jan; 8(3):4471-4483. PubMed ID: 27965460
[TBL] [Abstract][Full Text] [Related]
13. Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.
Wang H; Lu J; Tang J; Chen S; He K; Jiang X; Jiang W; Teng L
BMC Cancer; 2017 Mar; 17(1):191. PubMed ID: 28292264
[TBL] [Abstract][Full Text] [Related]
14. A novel antitumor piperazine alkyl compound causes apoptosis by inducing RhoB expression via ROS‑mediated c‑Abl/p38 MAPK signaling.
Chung KS; Han G; Kim BK; Kim HM; Yang JS; Ahn J; Lee K; Song KB; Won M
Cancer Chemother Pharmacol; 2013 Dec; 72(6):1315-24. PubMed ID: 24121479
[TBL] [Abstract][Full Text] [Related]
15. Alpha, 2'-dihydroxy-4,4'-dimethoxydihydrochalcone inhibits cell proliferation, invasion, and migration in gastric cancer in part via autophagy.
Wan B; Zhu J; Chang Q; Zhou H; Shi Z; Min L; Cai Y; Guan H
Biomed Pharmacother; 2018 Feb; 98():709-718. PubMed ID: 29306208
[TBL] [Abstract][Full Text] [Related]
16. Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer.
Xie C; Zhou X; Liang C; Li X; Ge M; Chen Y; Yin J; Zhu J; Zhong C
J Exp Clin Cancer Res; 2021 Aug; 40(1):266. PubMed ID: 34429133
[TBL] [Abstract][Full Text] [Related]
17. KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosis.
Tao J; Sun G; Li Q; Zhi X; Li Z; He Z; Chen H; Zhou A; Ye J; Xu G; Guan W; Zhang W
J Cell Physiol; 2020 Dec; 235(12):9388-9398. PubMed ID: 32342525
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Visfatin-Promoted Malignant Behavior in Breast Cancer Is Mediated Through c-Abl and STAT3 Activation.
Hung AC; Lo S; Hou MF; Lee YC; Tsai CH; Chen YY; Liu W; Su YH; Lo YH; Wang CH; Wu SC; Hsieh YC; Hu SC; Tai MH; Wang YM; Yuan SS
Clin Cancer Res; 2016 Sep; 22(17):4478-90. PubMed ID: 27036136
[TBL] [Abstract][Full Text] [Related]
19. Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.
Testoni E; Stephenson NL; Torres-Ayuso P; Marusiak AA; Trotter EW; Hudson A; Hodgkinson CL; Morrow CJ; Dive C; Brognard J
EMBO Mol Med; 2016 Feb; 8(2):105-16. PubMed ID: 26758680
[TBL] [Abstract][Full Text] [Related]
20. Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib.
Cheng Y; Hao Y; Zhang A; Hu C; Jiang X; Wu Q; Xu X
Int J Mol Med; 2018 Jan; 41(1):455-463. PubMed ID: 29115375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]